Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 label on the page. No substantive changes to study details or criteria are observed.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.1 replaces the previous Revision: v3.4.0 on the page; this is a minor metadata update with no impact on study data or functionality, and to avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedThe update adds a glossary toggle and a new label 'Last Update Submitted that Met QC Criteria', and updates the footer to 'Revision: v3.4.0' while removing the prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.